Month: April 2026
Tilray and other pot stocks soar as Trump is reportedly ready to reclassify cannabis
The move, which could open up medical research on cannabis as well as banking services for growers, follows an executive…
Tilray Brands (TLRY) Price Forecast: Cannabis Rescheduling Fuels Recovery
Trend Identification & Analysis: How to Read the Market’s Footprints Before the Crowd Does Cannabis-related stocks and ETFs have been…
MSOS: Trump’s Green Light – Why Cannabis Stocks Are Surging On Rescheduling News (Rating Upgrade)
MSOS is upgraded to Buy ahead of US cannabis rescheduling catalysts—Schedule III could end 280E taxes, boost MSO profits, and…
Why are cannabis stocks surging today?
Shares of major cannabis companies rallied sharply on Wednesday after reports suggested the Trump Administration could soon move to reclassify…
Curaleaf and more cannabis stocks soar. A regulatory breakthrough is coming.
Cannabis stocks were surging following multiple reports that the Department of Justice could move forward with reclassifying the drug as…
Canadian Cannabis Stocks Jump on Report U.S. May Move to Reclassify Marijuana
Canadian cannabis companies surged Wednesday after an Axios report said that the Trump Administration could move to reclassify marijuana.
5WPR Publishes the Cannabis Communications Gap Report, Documenting Why a $38.5 Billion Industry Operates with the Weakest Communications Infrastructure in American Business
WPR, one of the largest independent public relations and digital marketing firms in the United States, today published The Cannabis…
US set to move to reclassify marijuana as early as Wednesday, Axios reports
WASHINGTON, April 22 (Reuters) – The United States administration is expected to move to reclassify marijuana as soon as Wednesday,…
CBD Life Sciences Inc. (CBDL) Enters into Stock Purchase Agreement with FBC Holding Inc. to Acquire Mushroom Madness Inc. and Formrunner Apparel; Subsidiaries Now 100% Wholly Owned
SCOTTSDALE, AZ / ACCESS Newswire / April 22, 2026 /CBD Life Sciences Inc. (OTC:CBDL) CBD Life Sciences Inc. is proud…
From $500 to $1: Is Canopy Growth a Dead Stock Walking or the Ultimate Turnaround Play?
Err on the side of caution with this falling knife.
Recent Comments